Last reviewed · How we verify

NCT03824054: ENDO-RESECT

Quality of Life in Patients Undergoing Colorectal Resection for Deep Infiltrating Endometriosis

Completed Last updated 28 March 2019
What this trial tests

trial testing colorectal resection in Endometriosis in 50 participants. Completed in 30 November 2018.

Timeline
1 October 2005
Primary endpoint
30 November 2017
30 November 2018

Quick facts

Lead sponsorCatholic University of the Sacred Heart
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 October 2005
Primary completion30 November 2017
Estimated completion30 November 2018
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Catholic University of the Sacred Heart

Who can join

Adults 18 to 45, female only, with Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the quality of life of patients undergoing colorectal resection for deep infiltrating endometriosis of the bowel. Questionnaires about pre operative status have been submitted retrospectively, while post operative questionnaires have been submitted prospectively during last follow up visit

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL).
    Turco LC, Scaldaferri F, Chiantera V, Cianci S, et al · · 2020 · cited 17× · PMID 31758304 · DOI 10.1007/s00404-019-05382-8

Verify or expand the search:

Other trials of colorectal resection

Trials testing the same drug.

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Catholic University of the Sacred Heart trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03824054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing